October 16, 2007 - The link between gastroesophageal reflux disease (GERD) and obesity has long been established, but healthcare professionals have had little guidance as to whether obese patients with GERD* should be treated differently than normal-weight patients with GERD. Two studies about obesity and its relationship to GERD were presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting this week... AstraZeneca's Press Release-
Blog Archive
-
▼
2007
(18)
-
▼
October
(8)
- Genaera, Positive Phase 1 Trodusquemine (MSI-1436)
- Orexigen Therapeutics, Phase IIb Trial of Empatic ...
- VIVUS, Qnexa Quality of Life Data
- Orexigen Therapeutics, Third Phase III Trial for C...
- AstraZeneca, Body Mass Index Has No Effect on Reso...
- Sound Health Solutions, Support for Microsoft Heal...
- GSK , OTC weight loss product In Europe
- Nastech Pharmaceutical , Phase 2 Clinical Trial fo...
-
▼
October
(8)